Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBITDA ratio is N/A as of 2026-10-06T15:51:49.690Z.
Calculation as of: 2026-10-06T15:51:49.690Z.
Quote observation: 2026-10-06T15:50:04.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 758569c9a5200ff865148ece812cfee1584848efe17be54014067a65be913c54
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2023-09-29.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
N/A
EV/EBITDA RATIO AVG TTM
7.83x
EV/EBITDA RATIO AVG 3Y
16.18x
EV/EBITDA RATIO AVG 5Y
N/A
EV/EBITDA RATIO AVG 10Y
N/A
EV/EBITDA RATIO AVG 15Y
N/A
EV/EBITDA RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$64.37M
EV/EBITDA Ratio
N/A
TTM Avg
29.74x
3Y Avg
29.74x
5Y Avg
29.74x
Market Cap
$63.41M
EV/EBITDA Ratio
N/A
TTM Avg
250.18x
3Y Avg
250.18x
5Y Avg
250.18x
Market Cap
$67.80M
EV/EBITDA Ratio
255.71x
TTM Avg
103.53x
3Y Avg
75.29x
5Y Avg
64.49x
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| InterCure Ltd. (INCR) | $65.15M | N/A | 7.83x | 16.18x | N/A |
| Gossamer Bio, Inc. (GOSS)vs › | $66.29M | N/A | N/A | N/A | N/A |
| Pliant Therapeutics, Inc. (PLRX)vs › | $64.37M | N/A | 29.74x | 29.74x | 29.74x |
| Cingulate Inc. (CING)vs › | $66.00M | 0.23x | 0.03x | 0.03x | 0.03x |
| Heron Therapeutics, Inc. (HRTX)vs › | $63.41M | N/A | 250.18x | 250.18x | 250.18x |
| Alps Group Inc (ALPS)vs › | $64.06M | N/A | N/A | N/A | N/A |
| iBio, Inc. (IBIO)vs › | $67.52M | N/A | N/A | N/A | N/A |
| Kalaris Therapeutics Inc (KLRS)vs › | $62.54M | N/A | N/A | N/A | N/A |
| Champions Oncology, Inc. (CSBR)vs › | $67.80M | 255.71x | 103.53x | 75.29x | 64.49x |
| Fortress Biotech, Inc. (FBIO)vs › | $69.18M | N/A | N/A | N/A | N/A |
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBITDA RATIO |
|---|---|
| 2023-09-29 | 7.94x |
| 2023-09-28 | 7.81x |
| 2023-09-27 | 7.90x |
| 2023-09-26 | 7.77x |
| 2023-09-25 | 8.06x |
| 2023-09-22 | 8.18x |
| 2023-09-21 | 8.22x |
| 2023-09-20 | 8.26x |
| 2023-09-19 | 8.34x |
| 2023-09-18 | 8.47x |
| 2023-09-15 | 8.43x |
| 2023-09-14 | 8.55x |
| 2023-09-13 | 8.22x |
| 2023-09-12 | 7.81x |
| 2023-09-11 | 8.47x |
| 2023-09-08 | 8.38x |
| 2023-09-07 | 8.14x |
| 2023-09-06 | 8.55x |
| 2023-09-05 | 8.30x |
| 2023-09-01 | 7.90x |
| 2023-08-31 | 6.75x |
| 2023-08-30 | 6.44x |
| 2023-08-29 | 6.07x |
| 2023-08-28 | 6.35x |
| 2023-08-25 | 6.41x |
| 2023-08-24 | 6.35x |
| 2023-08-23 | 6.56x |
| 2023-08-22 | 6.53x |
| 2023-08-21 | 6.56x |
| 2023-08-18 | 6.16x |
| 2023-08-17 | 6.56x |
| 2023-08-16 | 6.56x |
| 2023-08-15 | 6.50x |
| 2023-08-14 | 6.56x |
| 2023-08-11 | 6.41x |
| 2023-08-10 | 6.41x |
| 2023-08-09 | 6.65x |
| 2023-08-08 | 6.90x |
| 2023-08-07 | 6.53x |
| 2023-08-04 | 6.53x |
| 2023-08-03 | 6.65x |
| 2023-08-02 | 6.65x |
| 2023-08-01 | 6.65x |
| 2023-07-31 | 6.68x |
| 2023-07-28 | 6.68x |
| 2023-07-27 | 6.68x |
| 2023-07-26 | 6.72x |
| 2023-07-25 | 6.65x |
| 2023-07-24 | 6.65x |
| 2023-07-21 | 6.87x |
| 2023-07-20 | 6.87x |
| 2023-07-19 | 6.96x |
| 2023-07-18 | 6.93x |
| 2023-07-17 | 6.68x |
| 2023-07-14 | 6.84x |
| 2023-07-13 | 6.93x |
| 2023-07-12 | 7.02x |
| 2023-07-11 | 7.09x |
| 2023-07-10 | 6.99x |
| 2023-07-07 | 6.62x |
| 2023-07-06 | 6.84x |
| 2023-07-05 | 6.62x |
| 2023-07-03 | 7.02x |
| 2023-06-30 | 7.02x |
| 2023-06-29 | 7.09x |
| 2023-06-28 | 7.36x |
| 2023-06-27 | 7.33x |
| 2023-06-26 | 7.46x |
| 2023-06-23 | 7.70x |
| 2023-06-22 | 7.92x |
| 2023-06-21 | 7.86x |
| 2023-06-20 | 7.95x |
| 2023-06-16 | 8.35x |
| 2023-06-15 | 8.35x |
| 2023-06-14 | 8.23x |
| 2023-06-13 | 8.63x |
| 2023-06-12 | 8.17x |
| 2023-06-09 | 8.57x |
| 2023-06-08 | 8.38x |
| 2023-06-07 | 8.10x |
| 2023-06-06 | 7.95x |
| 2023-06-05 | 7.64x |
| 2023-06-02 | 7.73x |
| 2023-06-01 | 7.67x |
| 2023-05-31 | 7.77x |
| 2023-05-30 | 7.77x |
| 2023-05-26 | 8.23x |
| 2023-05-25 | 8.10x |
| 2023-05-24 | 8.35x |
| 2023-05-23 | 8.66x |
| 2023-05-22 | 8.94x |
| 2023-05-19 | 9.03x |
| 2023-05-18 | 9.09x |
| 2023-05-17 | 9.03x |
| 2023-05-16 | 9.19x |
| 2023-05-15 | 9.74x |
| 2023-05-12 | 9.49x |
| 2023-05-11 | 9.77x |
| 2023-05-10 | 9.28x |
| 2023-05-09 | 9.12x |
| 2023-05-08 | 9.12x |
| 2023-05-05 | 8.78x |
| 2023-05-04 | 8.38x |
| 2023-05-03 | 8.48x |
| 2023-05-02 | 8.44x |
| 2023-03-31 | 4.16x |
| 2023-03-30 | 4.21x |
| 2023-03-29 | 4.21x |
| 2023-03-28 | 4.33x |
| 2023-03-27 | 4.29x |
| 2023-03-24 | 4.29x |
| 2023-03-23 | 4.42x |
| 2023-03-22 | 4.21x |
| 2023-03-21 | 3.93x |
| 2023-03-20 | 3.67x |
| 2023-03-17 | 3.69x |
| 2023-03-16 | 3.80x |
| 2023-03-15 | 3.93x |
| 2023-03-14 | 4.03x |
| 2023-03-13 | 4.06x |
| 2023-03-10 | 3.99x |
| 2023-03-09 | 4.29x |
| 2023-03-08 | 4.59x |
| 2023-03-07 | 4.70x |
| 2023-03-06 | 4.89x |
| 2023-03-03 | 5.21x |
| 2023-03-02 | 5.21x |
| 2023-03-01 | 5.14x |
| 2023-02-28 | 5.08x |
| 2023-02-27 | 5.40x |
| 2023-02-24 | 5.68x |
| 2023-02-23 | 5.80x |
| 2023-02-22 | 5.78x |
| 2023-02-21 | 5.72x |
| 2023-02-17 | 6.59x |
| 2023-02-16 | 6.61x |
| 2023-02-15 | 7.06x |
| 2023-02-14 | 7.17x |
| 2023-02-13 | 7.04x |
| 2023-02-10 | 7.49x |
| 2023-02-09 | 7.83x |
| 2023-02-08 | 7.87x |
| 2023-02-07 | 7.81x |
| 2023-02-06 | 7.76x |
| 2023-02-03 | 7.72x |
| 2023-02-02 | 8.28x |
| 2023-02-01 | 7.74x |
| 2023-01-31 | 7.66x |
| 2023-01-30 | 7.49x |
| 2023-01-27 | 7.81x |
| 2023-01-26 | 7.79x |
| 2023-01-25 | 7.70x |
| 2023-01-24 | 7.76x |
| 2023-01-23 | 7.66x |
| 2023-01-20 | 8.02x |
| 2023-01-19 | 8.04x |
| 2023-01-18 | 7.70x |
| 2023-01-17 | 7.68x |
| 2023-01-13 | 7.93x |
| 2023-01-12 | 8.15x |
| 2023-01-11 | 7.68x |
| 2023-01-10 | 7.85x |
| 2023-01-09 | 8.34x |
| 2023-01-06 | 7.91x |
| 2023-01-05 | 7.98x |
| 2023-01-04 | 7.62x |
| 2023-01-03 | 7.38x |
| 2022-12-30 | 6.85x |
| 2022-12-29 | 7.15x |
| 2022-12-28 | 6.78x |
| 2022-12-27 | 7.15x |
| 2022-12-23 | 7.98x |
| 2022-12-22 | 8.02x |
| 2022-12-21 | 8.49x |
| 2022-12-20 | 8.49x |
| 2022-12-19 | 8.77x |
| 2022-12-16 | 9.06x |
| 2022-12-15 | 8.94x |
| 2022-12-14 | 9.09x |
| 2022-12-13 | 9.60x |
| 2022-12-12 | 9.28x |
| 2022-12-09 | 9.41x |
| 2022-12-08 | 9.77x |
| 2022-12-07 | 9.85x |
| 2022-12-06 | 9.73x |
| 2022-12-05 | 10.17x |
| 2022-12-02 | 10.24x |
| 2022-12-01 | 10.17x |
| 2022-11-30 | 10.39x |
| 2022-11-29 | 9.83x |
| 2022-11-28 | 9.94x |
| 2022-11-25 | 10.49x |
| 2022-11-23 | 10.13x |
| 2022-11-22 | 10.60x |
| 2022-11-21 | 9.98x |
| 2022-11-18 | 10.47x |
| 2022-11-17 | 10.28x |
| 2022-11-16 | 10.90x |
| 2022-11-15 | 11.03x |
| 2022-11-14 | 11.54x |
| 2022-11-11 | 10.68x |
| 2022-11-10 | 10.43x |
| 2022-11-09 | 9.94x |
| 2022-11-08 | 10.34x |
| 2022-11-07 | 10.24x |
| 2022-11-04 | 10.04x |
| 2022-11-03 | 10.04x |
| 2022-11-02 | 10.28x |
| 2022-11-01 | 10.13x |
| 2022-10-31 | 10.09x |
| 2022-10-28 | 9.87x |
| 2022-10-27 | 9.96x |
| 2022-10-26 | 10.04x |
| 2022-10-25 | 10.00x |
| 2022-10-24 | 9.75x |
| 2022-10-21 | 9.96x |
| 2022-10-20 | 9.70x |
| 2022-10-19 | 10.13x |
| 2022-10-18 | 10.07x |
| 2022-10-17 | 10.11x |
| 2022-10-14 | 9.49x |
| 2022-10-13 | 9.96x |
| 2022-10-12 | 9.58x |
| 2022-10-11 | 9.68x |
| 2022-10-10 | 9.85x |
| 2022-10-07 | 10.04x |
| 2022-10-06 | 10.11x |
| 2022-10-05 | 9.77x |
| 2022-10-04 | 9.70x |
| 2022-10-03 | 9.83x |
| 2022-09-30 | 10.61x |
| 2022-09-29 | 10.63x |
| 2022-09-28 | 10.89x |
| 2022-09-27 | 10.45x |
| 2022-09-26 | 9.99x |
| 2022-09-23 | 9.91x |
| 2022-09-22 | 10.79x |
| 2022-09-21 | 10.89x |
| 2022-09-20 | 10.89x |
| 2022-09-19 | 10.89x |
| 2022-09-16 | 10.17x |
| 2022-09-15 | 10.32x |
| 2022-09-14 | 10.73x |
| 2022-09-13 | 10.89x |
| 2022-09-12 | 11.63x |
| 2022-09-09 | 11.30x |
| 2022-09-08 | 11.25x |
| 2022-09-07 | 11.12x |
| 2022-09-06 | 11.27x |
| 2022-09-02 | 11.48x |
| 2022-09-01 | 11.66x |
| 2022-08-31 | 12.33x |
| 2022-08-30 | 12.33x |
| 2022-08-29 | 12.33x |
| 2022-08-26 | 12.66x |
| 2022-08-25 | 12.84x |
| 2022-08-24 | 12.61x |
| 2022-08-23 | 13.12x |
| 2022-08-22 | 13.53x |
| 2022-08-19 | 12.53x |
Showing the most recent 260 of 660 data points. The chart above shows the full history.
